Pharmaceutical Contract Packaging Market Share

Statistics for the 2023 & 2024 Pharmaceutical Contract Packaging market share, created by Mordor Intelligence™ Industry Reports. Pharmaceutical Contract Packaging share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Pharmaceutical Contract Packaging Industry

The competitive landscape of the global pharmaceutical contract packaging market appears to be fragmented due to the presence of a large number of vendors. The major players with a significant share in the market are expanding their customer base across various regions. In addition, many companies are forming strategic and collaborative initiatives with multiple companies to increase their market share and profitability. Some of the recent developments in the market are:

  • May 2021 - Sharp, a contract packaging, clinical supply services company owned by UDG Healthcare plc, purchased new land as part of a USD 17 million investment in its Conshohocken, PA location. This land purchase will enable Sharp to add future capacity for cGMP packaging services and is part of a broader USD 43 million investment into its Pennsylvania operations, increasing the firm's blister packaging capacity by over 35%.
  • June 2020 - PCI Pharma has announced that it entered into a partnership agreement with Experic, a contract manufacturing organization, and pharmaceutical supply service company, to explore clinical and commercial manufacturing, packaging, and supply chain services driving collective growth for both parties.

Pharmaceutical Contract Packaging Market Leaders

  1. Ropack Inc.

  2. Sharp (UDG Healthcare)

  3. Reed-Lane Inc.

  4. PCI Pharma Services

  5. UNICEP Packaging LLC

*Disclaimer: Major Players sorted in no particular order

Pharmaceutical Contract Packaging Market Concentration

Pharmaceutical Contract Packaging Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)